News and Trends 4 Nov 2024Top biotech deals of October 2024 Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024. November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Oct 2024Six biotech companies advancing multiple sclerosis therapies Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease. October 24, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 8 Oct 2024Top biotech deals of September 2024 There were a number of deals that stirred the biopharma industry in September. We have listed the major collaborations that took place last month. October 8, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 30 Sep 2024The race for a bird flu vaccine: milestones and breakthroughs The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak. September 30, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Sep 2024Europe’s rising biotech stars: 10 startups to watch in 2024 The European biotech industry is bustling with activity this year. Here’s a list of 10 European biotech companies likely to make a big splash. September 26, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Sep 2024How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ’90s. September 25, 2024 - 9 minutesmins - By Jennifer Tsang Share WhatsApp Twitter Linkedin Email
In Depth 24 Sep 2024New partnership model on the rise: how VCs are helping Pharma hunt for their next blockbuster Discover how the recent Pfizer-Flagship alliance model sets a trend in pharma-VC partnerships, fostering innovation in drug development. September 24, 2024 - 9 minutesmins - By Monica Karpinski Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Sep 2024Six immunology biotech companies revolutionizing immune treatments in 2024 Find out more about six immunology companies that have recently raised impressive funds in the biotech industry. September 19, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Expert Advice 13 Sep 2024Stealth mode biotech startups: Everything you need to know Discover all you need to know about stealth mode biotech startups, including what stealth mode is and its advantages and disadvantages. September 13, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2024Long non-coding RNAs: what’s behind the growing “dark genome” buzz? Recent deals have zoned in on drugs that target long non-coding RNAs and major moves are currently being made on the R&D front. September 10, 2024 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 3 Sep 2024Adaptimmune: The long road toward finally bringing the first TCR-T cell therapy to the market Find out about Adaptimmune’s long – and somewhat bumpy – road toward bringing the first TCR-T therapy to the market. September 3, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 2 Sep 2024Are we in an AI bubble? Biotech AI startups’ value plummet and leads to restructuration Delve into the downturn AI is experiencing in biotech: Is the bubble bursting or is the market correcting the high expectations? September 2, 2024 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email